BHBrian Hansen

Brian Hansen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Brian Hansen has a total of 149 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Sex shapes capillary flows and oxygen extraction in the middle-aged mouse brain

    by Eugenio Gutiérrez-Jiménez, Boris Wied, Thomas B. Lindhardt, Signe H. Mikkelsen, Rasmus West Knopper, Christian Stald Skoven, Oliver B. Christensen, Vitalii Dashkovskyi, Filip Mrotek, Peter M. Rasmussen, et al.

    Sex differences in brain aging are well documented, but their origin within the cerebrovascular hierarchy remains unclear. Here we show that cortical blood flow is higher in female than male mice at 15 months of age, at a point when an earlier sex difference in pulsatility and resistance indices has already converged, pial vessel diameter shows no difference between sexes, and estrogen levels are similar between sexes. Using an indicator-dilution and intravascular oxygen measurements using two-photon microscopy, we found that capillary transit-time heterogeneity (CTH) scales more steeply with mean transit time in females, consistent with a passively regulated capillary network, and that this is accompanied by reduced oxygen extraction fraction (OEF) without deficit in arterial oxygen delivery. Spatial transcriptomics reveals that sex differences are organized into distinct regional programs, most prominently in white matter, where a male-associated myelin and axonogenesis signature accompanies reduced white matter volume in females. These molecular and structural differences coincide with elevated hippocampal microglial reactivity and an altered spatial search strategy in females, without any detectable differences in circulating markers of stress, blood-brain barrier integrity, or immunity. Together, these findings indicate that sex differences in the aging brain are expressed at the level of capillary flow regulation and regional tissue programs rather than through bulk cerebral blood flow alone, and that elevated blood flow in females can mask, rather than reflect, adequate tissue oxygenation.

  • Open Access

    Regulation of Choroid Plexus Bicarbonate Transporters Following Intraventricular Hemorrhage in Mice

    by Laura Øllegaard Johnsen, Rasmus Herløw, Rasmus West Knopper, Thomas Beck Lindhardt, Brian Hansen, Helle Hasager Damkier

    Posthemorrhagic hydrocephalus is a severe complication to intraventricular hemorrhage. The condition results in enlarged brain ventricles and increased intracranial pressure due to accumulation of cerebrospinal fluid (CSF). In this study, two mouse models of intraventricular hemorrhage were investigated: injection of lysed red blood cells (LRBC) and injection of autologous full blood. CSF secretion and ventricular volume were assessed using ventriculo‐cisternal perfusion and magnetic resonance imaging (MRI), while molecular and biochemical responses were analyzed by immunoblotting, RT‐qPCR, flame photometry, and blood‐gas measurements. LRBC injection induced a transient change in choroid plexus bicarbonate transporter expression, as the protein‐abundance of Ncbe, a basolateral sodium‐bicarbonate transporter, was reduced by 23% after 24 h but increased by 17% after 48 h. Injection with full blood transiently increased mRNA levels of the basolateral sodium‐bicarbonate transporter NBCn1 and Ncbe without altering protein expression. The luminal electrogenic sodium: bicarbonate transporter, NBCe2, was unaffected both at the RNA and protein level. Both models were validated using ventriculo‐cisternal perfusion demonstrating an increase in CSF volume by 70% in the IVH model after 24 h and 73% in the LRBC model after 3 days. No effect on secretion rate of CSF was detected. Additionally, in the LRBC model MRI was used to assess the time‐course of brain ventricle size following hemorrhage. Here, an overall volume increase of 30% was found in the hemorrhage‐induced mice compared to the control. These results demonstrate that both LRBC and full‐blood injections can induce ventricular enlargement in mice, but through different molecular responses. Neither model reproduced sustained CSF hypersecretion, underscoring that murine models of intraventricular hemorrhage display a milder form of pathophysiology compared to e.g. rats.


  • Open Access

    Development and assessment of an ex vivo imaging protocol for dental-dedicated MRI systems: A pilot study

    by Gabriela Salatino Liedke, Jennifer Christensen, Lucas Machado Maracci, Brian Hansen, Rubens Spin-Neto

    Liedke GS, et al. Imaging Sci Dent. 2026 Jan;56:e4. https://doi.org/10.5624/isd.20250228

  • Open Access

    Neurodegeneration and energy depletion in MS: Links between tissue integrity loss and microvascular changes in white matter disease

    by Linda Sundvall, Mikkelsen Irene Klærke, Brian Hansen, Simon Fristed Eskildsen, Mette Madsen Hjørringgaard, Mikkel Karl Emil Nygaard, Peter Vestergaard Rasmussen, Thor Petersen, Leif Østergaard


  • Open Access

    Isoflurane anesthesia alters 31P magnetic resonance spectroscopy markers compared to awake mouse brain

    by Saba Molhemi, Rasmus West Knopper, Christian Stald Skoven, Thomas Beck Lindhardt, Caroline Degel, Leif Østergaard, Brian Hansen

    Normal brain function hinges on energy-intensive processes. Consequently, alterations to the brain’s metabolic state are common hallmarks in several pathological conditions. Phosphorus Magnetic Resonance Spectroscopy ( 31 P MRS) is a noninvasive method for measuring key markers of brain energy metabolism, including adenosine triphosphate (ATP), inorganic phosphate (Pi), and phosphocreatine (PCr), as well as markers for cell membrane phospholipid turnover, phosphomonoester (PME) and phosphodiester (PDE). Preclinical rodent 31 P MRS has so far been done under anesthesia - with isoflurane being one of the most commonly used anesthetic agents. The use of isoflurane in 31 P MRS is a concern, as anesthetics are known to affect neuronal activity and energy metabolism in the brain. Its use therefore comes with a risk of perturbing brain physiology. Awake mouse MRS avoids this and allows the effect of isoflurane to be quantified. Thus, we here compare mouse brain 31 P MRS in awake MR-habituated mice and isoflurane anesthesia. We find that 31 P metabolite levels differ between the awake state and isoflurane anesthesia in mice. Our findings show that low-dose isoflurane anesthesia reduces PCr levels in the mouse brain and is accompanied by decreases in intracellular pH and decreased PME levels.


  • Open Access

    Genetic rescue of pathogenic O-GlcNAc dyshomeostasis associated with microcephaly and motor deficits

    by Florence Authier, Iria Esperon-Abril, Kévin-Sébastien Coquelin, Christian Stald Skoven, Simon Fristed Eskildsen, Nina Ondruskova, Andrew T. Ferenbach, Jesper Skovhus Thomsen, Brian Hansen, Daan M. F. van Aalten

    Missense variants in O-GlcNAc transferase (OGT) result in OGT congenital disorder of glycosylation (OGT-CDG), an intellectual disability syndrome associated with O-GlcNAc dyshomeostasis and a range of neurodevelopmental defects. Inhibition of O-GlcNAcase (OGA), the enzyme responsible for removing protein O-GlcNAcylation, has been explored as a target for modulating brain O-GlcNAc homeostasis in neurodegenerative diseases and may also be a target for OGT-CDG. Here, we describe an OGT-CDG mouse line that exhibits microcephaly, motor deficits, and brain O-GlcNAc dyshomeostasis, closely mirroring patient symptoms. We genetically explored OGA as a target for OGT-CDG by crossing these mice with a line carrying catalytically inactive OGA. Encouragingly, this partially restored O-GlcNAc homeostasis in brain and blood, although it did not result in significant phenotypic rescue. These findings suggest that OGA inhibition can modulate enzymatic imbalance in OGT-CDG mice, and that blood can be used to monitor the effects of interventions targeting O-GlcNAc dyshomeostasis.


  • Open Access

    Role for NF-κB in herpes encephalitis pathology in mice genocopying an inborn error of IRF3-IFN immunity

    by Manja Idorn, Xiangning Ding, Stefanie Fruhwürth, Søren Holste, Line S. Reinert, Christian S. Skoven, Katarina Türner-Stenström, Alexander Schmitz, Mikkel H. Vendelbo, Benedicte P. Ulhøi, et al.

    Herpes simplex encephalitis (HSE) is a devastating disease with high mortality and serious sequelae. Genetic defects in the IFN-I pathway predispose individuals to HSE, but underlying mechanisms remain unclear. Using transgenic mice with the IRF3 R278Q mutation, ortholog to HSE-associated IRF3 R285Q, and iPSC-derived CNS cells from a pediatric patient carrying the variant, we investigated mechanisms in HSE. IRF3 R278Q transgenic mice exhibited aggravated HSV-1 brain disease and elevated CNS viral loads. Accordingly, microglia from the IRF3 R278Q mice showed reduced HSV-1–induced IFN-I expression. Surprisingly, unaltered Ifnb levels along with elevated levels of inflammatory cytokines were detected in infected transgenic mouse brains, correlating with higher viral load. This was successfully modeled in patient microglia. Multiomics-based immune profiling revealed an inflammatory monocyte population in the infected IRF3 R278Q mouse brain, which was enriched for NF-κB activation. NF-κB inhibition improved disease outcomes, surpassing the effect of acyclovir. These findings suggest that IFN-I defects lead to elevated levels of HSV-1 replication in the brain, which subsequently enables NF-κB–driven immunopathology, offering insights with therapeutic potential.


  • Open Access

    A large animal model for focal stroke: Photothrombotic lesion in the cortex of Danish Landrace pigs

    by V.H. Kuang, C.S. Skoven, S. Arvin, L.M. Fitting, K.R. Drasbek, B. Hansen, D. Orlowski, J.C.H. Sørensen


  • Open Access

    Comprehensive Analysis of the 5xFAD Mouse Model of Alzheimer’s Disease Using dMRI, Immunohistochemistry, and Neuronal and Glial Functional Metabolic Mapping

    by Emil W. Westi, Saba Molhemi, Caroline Termøhlen Hansen, Christian Stald Skoven, Rasmus West Knopper, Dashne Amein Ahmad, Maja B. Rindshøj, Aishat O. Ameen, Brian Hansen, Kristi A. Kohlmeier, et al.

    Alzheimer’s disease (AD) is characterized by complex interactions between neuropathological markers, metabolic dysregulation, and structural brain changes. In this study, we utilized a multimodal approach, combining immunohistochemistry, functional metabolic mapping, and microstructure sensitive diffusion MRI (dMRI) to progressively investigate these interactions in the 5xFAD mouse model of AD. Our analysis revealed age-dependent and region-specific accumulation of key AD markers, including amyloid-beta (Aβ), GFAP, and IBA1, with significant differences observed between the hippocampal formation and upper and lower regions of the cortex by 6 months of age. Functional metabolic mapping validated localized disruptions in energy metabolism, with glucose hypometabolism in the hippocampus and impaired astrocytic metabolism in the cortex. Notably, increased cortical glutaminolysis suggested a shift in microglial metabolism, reflecting an adaptive response to neuroinflammatory processes. While dMRI showed no significant microstructural differences between 5xFAD and wild-type controls, the study highlights the importance of metabolic alterations as critical events in AD pathology. These findings emphasize the need for targeted therapeutic strategies addressing specific metabolic disturbances and underscore the potential of integrating advanced imaging with metabolic and molecular analyses to advance our understanding of AD progression.